צמיחת מכירות ב-12 חודשים נגררים: Morphic Holding Corp (MORF)

סמל מסחרי של morphictx.com (MORF)

Morphic Holding, Inc. (MORF) maintains high authority in colitis therapy, supported by stable leadership that ensures R&D development prior to a merger with a tech giant. The year-over-year percentage change in sales volume for the LTM clearly demonstrates this trend, where the -91.50 mark indicates the current level of expansion. However, geopolitical instability and logistics disruptions in international testing create risks for the company's final financial results.

MORF - צמיחת מכירות משנה לשנה (TTM) Morphic Holding Inc בטווח 11.02.2024 - 20.02.2024

Morphic - פילוחים אנליטיים ומדדי מפתח (MORF)

- מדדי שווי החברה בבורסה:
אנליטיקה מסכמת של החברה:Morphic Holding Corp
מוצר סדרתי של morphictx.com

Amid the integration of Morphic Holding, Inc. (MORF) into a major player's structure and the development of its drug pipeline, this metric reflects the efficiency of the business's organic expansion. The calculation of the rolling annual revenue growth neutralizes seasonal distortions, allowing a real-time assessment of demand dynamics and the fundamental stability of Morphic Holding, Inc. (MORF) beyond market noise through the historical trend of year-over-year revenue growth over the last 12 months.